Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
70
7 regions24 stories13 countries
Europe
6 stories- UK expert backs Jersey decision to allow GPs to prescribe medical cannabis
GBMedicallink no longer available
- German pharmaceutical distributor CC Pharma to be acquired by Aphria
DEBusiness & Investmentlink no longer available
- UK guidelines restricting patient access to cannabis despite law change
GBMedicallink no longer available
- Ireland slowly progressing with medical cannabis access scheme
IEMedicallink no longer available
- Canopy to invest €100 million in European expansion
EUBusiness & Investmentlink no longer available
- Spanish cannabis businesses flourishing despite plant illegality
ESBusiness & Investmentlink no longer available
United States
2 stories- US midterm results and AG Jeff Sessions resignation good news for cannabis
USRegulationlink no longer available
- BlackRock will invest in cannabis once US banking issue resolved
USBusiness & Investmentlink no longer available
Canada
1 story- Legalisation in Canada and US could increase acceptance in Asia
CAUSRegulationlink no longer available
LATAM & Caribbean
4 stories- Mexico's President-Elect endorses Supreme Court decision on cannabis use
MXRegulationlink no longer available
- Uruguay reviewing up to 20 licence applications
UYRegulationlink no longer available
- Chemesis International to acquire Colombian cannabis company La Finca
COBusiness & Investmentlink no longer available
- Mexican Senator introduces bill to legalise cannabis production and sale
MXRegulationlink no longer available
Africa & Middle East
2 stories- Israeli health ministry issues stop work order to Tikun Olam
ILRegulationlink no longer available
- Canadian companies losing interest in Israeli market as exports stall
ILBusiness & Investmentlink no longer available
Oceania
4 stories- New Zealand health department awards Helius Therapeutics cannabis growing licence
NZMedicallink no longer available
- Cannex Capital invests in New Zealand cannabis start-up Soma Group
NZBusiness & Investmentlink no longer available
- Aphria's Australian partner Althea secures manufacturing licence
AUBusiness & Investmentlink no longer available
- Aleafia Health to acquire 10% stake in Australian company CannaPacific
AUBusiness & Investmentlink no longer available
Rest of world
2 stories- WHO meeting this month to review cannabis policies
Regulationlink no longer available
- Bank of Montreal predicts CAD$194 billion global cannabis market in 7 years
Business & Investmentlink no longer available
Health & Science
- Study finds cannabinoids have beneficial effect on malignant melanoma
Health & Sciencelink no longer available
- Cannabidiol can improve behavioural outbreaks in children with autism
Health & Sciencelink no longer available
- Biosynthesis of cannabinoids could have profound effects on cannabis industry
Health & Sciencelink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report